Ryman Healthcare fell 31c or 1.96 per cent to $15.51 a day before it reports its latest financial result. Goodson said it should be a tough result for them, but that's ancient history. The market will be looking at Ryman's outlook and it is a beneficiary of the housing bubble.
He said a2 Milk was conflicted by the market's long and short-term views after providing a trading update at its annual meeting. There were fears of a downgrade because of the daigou sales channel disruption but that didn't eventuate, and there are still fears about a2 Milk's performance in the second half of the financial year.
Summerset Group Holdings rose 17c to $10.75 after receiving consent from the Environment Court to build its $150m retirement village in Boulcott, Lower Hutt, with 155 independent living apartments and villas, 56 serviced apartments and a 30-bed care centre.
Other risers were Pushpay Holdings, increasing 10c to $7.29; Fletcher Building, gaining 8c to $5.51; Infratil climbing 8c to $5.60; Napier Port, recovering 4c to $3.58; Millennium & Copthorne Hotels up 6c or 3.06 per cent to $2.02; and SkyCity Entertainment climbing 6c or 1.99 per cent to $3.08.
Stride Property is buying the 16-level Grant Thornton House in downtown Wellington for $84.5m, with an initial yield of 6 per cent, and its share price increased 2c to $2.32.
Precinct Properties said it is committed to developing the Bowen Campus second building in Wellington with KPMG as a tenant. It is paying a first quarter dividend of 1.625c a share on December 10, and Precinct's share price remained unchanged at $1.765.
Australia and New Zealand personal lender Harmoney Corp debuted on the NZX and ASX exchanges after raising A$92.5m at A$3.50 ($3.69) a share in its initial public offer. Its share price on the New Zealand market was down 17.7c or 4.72 per cent to $3.57. Harmoney's major shareholders include Trade Me at 7.6 per cent, Heartland Group Holdings 8.44 per cent, Lookman Family Trust 8.98 per cent and Kirwood Capital 8.7 per cent.
The United States markets fell overnight, with investors unnerved by the rising Covid-19 cases which have hit 11.87 million and hospitalisations reaching record highs.
Pfizer and BioNTech will soon submit their coronavirus vaccine for FDA approval after releasing final late-stage trial data that was even stronger than the initial reading, but this didn't move investors.
The Dow Jones Industrial Average was down 1.16 per cent to 29,438.42, the S&P 500 Index also fell the same amount to 3567.79 and the Nasdaq Composite declined 0.82 per cent to 11,801.60. Electric vehicle maker Tesla continued to stand out, rising 10.1 per cent to US$486.64 ($704.77).